ClinicalTrials.gov
public full text
Public Domain
Scalp Cooling in MBC
This research is being done to compare rates of hair loss of people with metastatic breast who use scalp cooling versus those who do not use scalp cooling after receiving standard of care treatment with either sacituzumab govitecan, trastuzumab deruxtecan, or eribulin. The name of the study intervention involved in this study is: * Paxman Scalp Cooling System
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pilot Study on The Flanks of Asian Patients#1096885
- Effects of Surface Cooling On Stroke Outcome triaL (COOL)#864744
- Dose Response Effect of Drop Jumps on Bone Characteristics#1057556
- Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium#859699
- Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata#831335
Record · ID 1171444
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive